Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
Newly published data indicates that widely available medications for chronic lymphocytic leukemia (CLL) have steadily improved overall survival rates over most of the past three decades.
One patient s experience with Hodgkin s lymphoma some 30 years ago shows just how much treatment approaches have changed; some of the treatments of the past now sound almost barbaric, says an expert.